Paul S. Herendeen
2016 - Valeant Pharmaceuticals International
Herendeen received $15.9M in option awards, accounting for 50.80% of the total pay in 2016.
Herendeen also received $10.4M in bonus, $346.2K in salary and $4.7M in stock awards.
In 2016, Paul S. Herendeen's compensation ranked 40th out of 14,075 executives tracked by ExecPay. In other words, Herendeen earned more than 99.7% of executives.
Chemicals And Allied Products
We found two more compensation records of executives who worked with Paul S. Herendeen at Valeant Pharmaceuticals International in 2016.